Detailed answers about N1 PHARMACEUTICAL PARTNERS LIMITED, including incorporation, status, business activity, and accounts information.
When was N1 PHARMACEUTICAL PARTNERS LIMITED founded?
N1 PHARMACEUTICAL PARTNERS LIMITED was officially incorporated on 6 February 2025 and is registered under company number 16235093. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is N1 PHARMACEUTICAL PARTNERS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of N1 PHARMACEUTICAL PARTNERS LIMITED?
N1 PHARMACEUTICAL PARTNERS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does N1 PHARMACEUTICAL PARTNERS LIMITED do?
N1 PHARMACEUTICAL PARTNERS LIMITED operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 21200 - Manufacture of pharmaceutical preparations, 32500 - Manufacture of medical and dental instruments and supplies. These SIC codes provide insight into the company's business activities and industry focus.
What is N1 PHARMACEUTICAL PARTNERS LIMITED's registered address?
The registered office address of N1 PHARMACEUTICAL PARTNERS LIMITED is LONGFREY COTTAGE DORKING ROAD, CHILWORTH, GUILDFORD, ENGLAND, GU4 8RH. This is the official address filed with Companies House for legal and statutory correspondence.
Is N1 PHARMACEUTICAL PARTNERS LIMITED financially stable?
Financial accounts for N1 PHARMACEUTICAL PARTNERS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.